Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Sep 1:5:476.
doi: 10.1186/1756-0500-5-476.

Non-invasive prenatal diagnostic test accuracy for fetal sex using cell-free DNA a review and meta-analysis

Affiliations
Review

Non-invasive prenatal diagnostic test accuracy for fetal sex using cell-free DNA a review and meta-analysis

Caroline F Wright et al. BMC Res Notes. .

Abstract

Background: Cell-free fetal DNA (cffDNA) can be detected in maternal blood during pregnancy, opening the possibility of early non-invasive prenatal diagnosis for a variety of genetic conditions. Since 1997, many studies have examined the accuracy of prenatal fetal sex determination using cffDNA, particularly for pregnancies at risk of an X-linked condition. Here we report a review and meta-analysis of the published literature to evaluate the use of cffDNA for prenatal determination (diagnosis) of fetal sex. We applied a sensitive search of multiple bibliographic databases including PubMed (MEDLINE), EMBASE, the Cochrane library and Web of Science.

Results: Ninety studies, incorporating 9,965 pregnancies and 10,587 fetal sex results met our inclusion criteria. Overall mean sensitivity was 96.6% (95% credible interval 95.2% to 97.7%) and mean specificity was 98.9% (95% CI = 98.1% to 99.4%). These results vary very little with trimester or week of testing, indicating that the performance of the test is reliably high.

Conclusions: Based on this review and meta-analysis we conclude that fetal sex can be determined with a high level of accuracy by analyzing cffDNA. Using cffDNA in prenatal diagnosis to replace or complement existing invasive methods can remove or reduce the risk of miscarriage. Future work should concentrate on the economic and ethical considerations of implementing an early non-invasive test for fetal sex.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow chart of studies identified by the search strategy and the process of eligibility and inclusion.
Figure 2
Figure 2
Individual study estimates of sensitivity and 1-specificity of cffDNA diagnosis of fetus sex, ordered by year of publication.
Figure 3
Figure 3
ROC plot of sensitivity against (1 − specificity) for 90 studies of the diagnosis of fetal sex by cffDNA. Each point on the graph represents a pair of sensitivity and specificity from a study. The more weight the study is given, the larger the point. Summary sensitivity and specificity is marked by a red square.

References

    1. Baird PA, Anderson TW, Newcombe HB, Lowry RB. Genetic disorders in children and young adults: a population study. Am J Hum Genet. 1988;42(5):677–693. - PMC - PubMed
    1. Mujezinovic F, Alfirevic Z. Procedure-related complications of amniocentesis and chorionic villous sampling: a systematic review. Obstet Gynecol. 2007;110(3):687–694. doi: 10.1097/01.AOG.0000278820.54029.e3. - DOI - PubMed
    1. Lo YM, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CW. et al. Presence of fetal DNA in maternal plasma and serum. Lancet. 1997;350(9076):485–487. doi: 10.1016/S0140-6736(97)02174-0. - DOI - PubMed
    1. Lo YM, Tein MS, Lau TK, Haines CJ, Leung TN, Poon PM. et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet. 1998;62(4):768–775. doi: 10.1086/301800. - DOI - PMC - PubMed
    1. Lo YM, Zhang J, Leung TN, Lau TK, Chang AM, Hjelm NM. Rapid clearance of fetal DNA from maternal plasma. Am J Hum Genet. 1999;64(1):218–224. doi: 10.1086/302205. - DOI - PMC - PubMed